When: MACD histogram establishing a higher low from current -0.40

Then: Second confirmation toward re-engagement (2 of 4 required)

When: RSI bullish divergence at oversold levels

Then: Third confirmation toward re-engagement (3 of 4 required)

When: Forward EPS reaffirmation at $6.00+ with Nutrition stabilization

Then: Fourth confirmation toward re-engagement (4 of 4 required)

EXIT FULLY (80-100%) or HOLD WITH TIGHTER RISK FRAMEWORK: hard stop below May 2026 low at $81.39 and smaller position size; reject proposed 50-70% trim with residual 30-50% as inadequate

• Net debt expanded by 518% in a single quarter, now at $27 billion, with $20 billion increase in net debt
• FCF collapsed from $2.6 billion to $916 million (65% QoQ decline); annualized coverage drops to 22%
• $4.1 billion annualized dividend against $7.2 billion TTM FCF is 57% covered; dividend not sacrosanct in leveraged company
• Operating margin compressed from 18-20% to 12%
• Stop at $100.70 on $96.50 entry is above entry and provides no real downside protection
• Proposed trim leaves residual 30-50% exposed to negatively skewed distribution with 13-16% downside skew
• ATR declining, volume not climactic, Bollinger band rolling over signals low-liquidity drift lower, not capitulation
• May 2026 low at $81.39 is realistic target if Q3 disappoints and death cross accelerates
• Death cross in place with no bullish divergence yet
• Institutional distribution on declining volume confirmed
• Trim structure is half-measure: doesn't protect capital on residual, doesn't capture upside, leaves operational risk
• Dividend is competing claim on cash flow before equity holders in leveraged capital structure
• ABT trades 8-15M shares; capitulation would require 20M+ volume spike not yet seen
• Proposed exit of 50-70% at $96.50 is insufficient given confirmed downtrend and confirmed capital structure change

→ vs aggressive: Residual 30-50% position framed as 'free option' on Q3 beat-and-raise is not free; continues mark-to-market exposure to deteriorating capital structure with 13-16% downside skew, warranting full exit not trim

→ vs aggressive: Stop at $100.70 on $96.50 entry is above entry and meaningless; provides no downside protection on residual position

→ vs aggressive: Dividend yield argument fails because FCF run-rate decline drops coverage to 22%; dividend is competing claim on cash flow before equity holders

→ vs aggressive: ATR declining, volume not climactic, Bollinger rolling over indicates low-liquidity drift lower, not capitulation; argues for more cautious exit not less

→ vs neutral: HOLD position is 100% allocation to negatively skewed distribution with maximum drawdown risk in exchange for 2.55% yield; not defensible capital preservation

→ vs neutral: Beta of 0.586 and defensive healthcare classification irrelevant; Polymarket pricing 97% odds of zero Fed cuts in 2026 removes monetary catalyst, recession odds at 8% removes flight-to-safety bid

→ vs neutral: Benign macro is worst-case backdrop for ABT: no relief valve and passive exposure to deteriorating situation

Execute 50-70% trim at 96.50, fix stop architecture (replace 100.70 stop with either trailing stop or hard stop below 200 SMA at 103.29 or May low at 81.39), size residual by defined dollar portfolio risk, set pre-defined Q3 earnings rules (5%+ EPS beat with maintained/raised guidance = hold residual; 5%+ miss or guide-down = exit residual next day), do not redeploy freed capital into AI momentum names, and set rule-based re-entry triggers (bullish MACD crossover with RSI higher low technically; operating margin recovery to 15%+ fundamentally).

• Capital structure transformation is the dominant story: 518% net debt expansion, D/E ratio from 26 to 63.2, operating margin compression from 18-20% to 12%
• Direction of risk is real and technicals confirm fundamental deterioration, warranting 50-70% position reduction
• Forward P/E of 15.9x based on consensus EPS of $6.07 represents a valuation floor that the aggressive bear case incorrectly dismisses; implied forward P/E of 13-14x and 30-40% earnings cut represents a tail scenario, not base case
• RSI below 26 in a 0.59 beta name with 50-year dividend history is not the same as high-beta momentum names; mean reversion is more reliable in lower beta names
• Bounce to 100-103 is expected before next leg lower and represents a chance to trim the residual at better levels, not a buying opportunity
• Aggressive analyst's recommendation to redeploy into IBM, Micron, and AI infrastructure names at or near highs is explicit selling low and buying high on the wrong side of rotation
• Conservative analyst's alternatives (80-100% exit or full hold with 15.6 point stop from 96.50 to 81.39) actually have MORE dollar risk than the trim being criticized; trim has limited downside because only 30-50% of capital remains exposed
• Current stop at 100.70 is a confirmation bias device placed above entry rather than genuine risk control; requires either trailing stop on residual, hard stop below 200 SMA (103.29) or May swing low (81.39), or pre-defined Q3 earnings-triggered stop
• Q1 2026 FCF of 916 million was depressed by one-time working capital build post-acquisition; TTM FCF of 7.2 billion (Q4 2025: 2.6B, Q3 2025: 2.3B, Q2 2025: 1.5B) is the correct coverage basis, not single worst quarter; 57% TTM dividend coverage is real with company investment grade and 50 consecutive years of dividend increases
• Residual position sizing should be defined by maximum loss as percentage of total portfolio risk, not percentage of original ABT allocation
• Capital from trim should sit in cash or low-duration instruments; capital preservation is also a return
• Re-entry should be rule-based: technical trigger (bullish MACD crossover with RSI higher low) combined with fundamental trigger (operating margin recovery toward 15% or better)

→ vs aggressive: Overcooked conviction on timing and completely dismissing forward P/E of 15.9x as valuation floor; implied forward P/E of 13-14x and 30-40% earnings cut is a tail scenario, not base case

→ vs aggressive: Bounce dismissal ignores lower beta mean reversion reliability; RSI below 26 in 0.59 beta name with 50-year dividend history is not same as high-beta momentum names; leaving 4-7% of price on the table by saying 'sell now' rather than using bounce to trim residual

→ vs aggressive: Advocating redeployment into IBM, Micron, and AI infrastructure names that have already had their run is explicitly selling a defensive name at multi-month lows to buy momentum names at or near cycle highs; this is market timing on the wrong side of rotation, not asymmetric risk management

→ vs conservative: Critique of trim as 'half-measure' is incorrect; conservative alternatives (80-100% exit or full hold with 15.6 point stop) actually have MORE dollar risk than the trim; full exit risks worse fill than 96.50, full hold has 100% capital exposure; trim limits downside because only 30-50% of capital remains exposed

→ vs conservative: Q1 2026 FCF of 916 million annualized to 3.66 billion with 22% coverage on 4.1B dividend extrapolates a one-time trough; correct basis is TTM FCF of 7.2 billion yielding 57% coverage; dividend is investment grade protected for 12-18 months minimum

→ vs conservative: Stop at 100.70 is a confirmation bias device placed above entry; genuine stop architecture requires either trailing stop, hard technical stop below 200 SMA (103.29) or May low (81.39), or pre-defined Q3 earnings trigger—not an emotional stop above cost